Compare Danaos Corporation (DAC) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Danaos Corporation vs Regeneron Pharmaceuticals Inc — how do they compare? Danaos Corporation trades at $129.89 (market cap $2.35B), while Regeneron Pharmaceuticals Inc trades at $655.5 (market cap $69.52B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 29.6× Danaos Corporation's market cap, and Danaos Corporation pays the higher dividend (2.78%). Which is the better fit depends on your goals.
| DAC | REGN | |
|---|---|---|
Market Cap | $2.35B | $69.52B |
Sector | Technology | Health |
52-Week High | $134.63 | $812.27 |
52-Week Low | $84.05 | $542.52 |
Enterprise Value | $2.36B | $63.47B |
Dividend Yield | 2.78% | 0.57% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Danaos Corporation
Danaos is a leading international owner of containerships, providing seaborne transportation services globally. It charters its fleet of vessels to major shipping lines across Asia, Europe, and the Americas.
Read more on DAC →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
